- Home
- RDCM vs CRBU Comparison
RDCM vs CRBU Comparison
Compare RDCM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- CRBU
- Stock Information
- Founded
- RDCM 1985
- CRBU 2011
- Country
- RDCM Israel
- CRBU United States
- Employees
- RDCM N/A
- CRBU 147
- Industry
- RDCM Computer peripheral equipment
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- RDCM Technology
- CRBU Health Care
- Exchange
- RDCM Nasdaq
- CRBU Nasdaq
- Market Cap
- RDCM 203.7M
- CRBU 174.1M
- IPO Year
- RDCM 1997
- CRBU 2021
- Fundamental
- Price
- RDCM $13.72
- CRBU $1.87
- Analyst Decision
- RDCM Strong Buy
- CRBU Strong Buy
- Analyst Count
- RDCM 1
- CRBU 3
- Target Price
- RDCM $18.00
- CRBU $6.67
- AVG Volume (30 Days)
- RDCM 67.7K
- CRBU 834.5K
- Earning Date
- RDCM 08-13-2025
- CRBU 11-05-2025
- Dividend Yield
- RDCM N/A
- CRBU N/A
- EPS Growth
- RDCM 79.61
- CRBU N/A
- EPS
- RDCM 0.56
- CRBU N/A
- Revenue
- RDCM $66,334,000.00
- CRBU $9,121,000.00
- Revenue This Year
- RDCM $18.07
- CRBU $9.23
- Revenue Next Year
- RDCM $11.52
- CRBU N/A
- P/E Ratio
- RDCM $24.55
- CRBU N/A
- Revenue Growth
- RDCM 18.18
- CRBU N/A
- 52 Week Low
- RDCM $9.23
- CRBU $0.66
- 52 Week High
- RDCM $15.98
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- RDCM 56.64
- CRBU 49.47
- Support Level
- RDCM $12.89
- CRBU $1.78
- Resistance Level
- RDCM $13.50
- CRBU $1.96
- Average True Range (ATR)
- RDCM 0.47
- CRBU 0.13
- MACD
- RDCM 0.06
- CRBU -0.01
- Stochastic Oscillator
- RDCM 89.11
- CRBU 32.63
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.